WO2005053645A1 - Method for administration tiotropium - Google Patents
Method for administration tiotropium Download PDFInfo
- Publication number
- WO2005053645A1 WO2005053645A1 PCT/SE2004/001791 SE2004001791W WO2005053645A1 WO 2005053645 A1 WO2005053645 A1 WO 2005053645A1 SE 2004001791 W SE2004001791 W SE 2004001791W WO 2005053645 A1 WO2005053645 A1 WO 2005053645A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dose
- medicament
- dry powder
- powder
- doses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04801708A EP1991202B1 (en) | 2003-12-03 | 2004-12-02 | Method for administration tiotropium |
PL04801708T PL1991202T3 (en) | 2003-12-03 | 2004-12-02 | Method for administration tiotropium |
DK04801708.1T DK1991202T3 (en) | 2003-12-03 | 2004-12-02 | Method of administration of tiotropium |
AU2004294887A AU2004294887B2 (en) | 2003-12-03 | 2004-12-02 | Method for administration tiotropium |
AT04801708T ATE448776T1 (en) | 2003-12-03 | 2004-12-02 | METHOD FOR ADMINISTRATION OF TIOTROPIUM |
DE602004024261T DE602004024261D1 (en) | 2003-12-03 | 2004-12-02 | METHOD FOR THE ADMINISTRATION OF TIOTROPIUM |
CA002547660A CA2547660A1 (en) | 2003-12-03 | 2004-12-02 | Inhalation administration of tiotropium in high amount of metered dose |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0303270A SE0303270L (en) | 2003-12-03 | 2003-12-03 | Method of administration of tiotropium |
SE0303270-3 | 2003-12-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005053645A1 true WO2005053645A1 (en) | 2005-06-16 |
Family
ID=29778163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2004/001791 WO2005053645A1 (en) | 2003-12-03 | 2004-12-02 | Method for administration tiotropium |
Country Status (15)
Country | Link |
---|---|
US (2) | US20050121026A1 (en) |
EP (1) | EP1991202B1 (en) |
AT (1) | ATE448776T1 (en) |
AU (1) | AU2004294887B2 (en) |
CA (1) | CA2547660A1 (en) |
CY (1) | CY1110625T1 (en) |
DE (1) | DE602004024261D1 (en) |
DK (1) | DK1991202T3 (en) |
ES (1) | ES2333725T3 (en) |
PL (1) | PL1991202T3 (en) |
PT (1) | PT1991202E (en) |
SE (1) | SE0303270L (en) |
SI (1) | SI1991202T1 (en) |
WO (1) | WO2005053645A1 (en) |
ZA (1) | ZA200604254B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11090294B2 (en) | 2009-12-01 | 2021-08-17 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1682541E (en) * | 2003-11-03 | 2010-04-14 | Boehringer Ingelheim Int | Method for producing tiotropium salts |
PL2083007T3 (en) * | 2003-11-03 | 2013-09-30 | Boehringer Ingelheim Int | Tiotropium salts, method for creating same and medicinal formulations containing same |
SE0303270L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Method of administration of tiotropium |
SE0303571D0 (en) * | 2003-12-03 | 2003-12-22 | Microdrug Ag | Medical product for moisture-sensitive drugs |
SE0303269L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medical product |
WO2005053647A1 (en) * | 2003-12-03 | 2005-06-16 | Microdrug Ag | Medical product containing tiotropium |
SE0303570L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Moisture-sensitive medical product |
SE0303569L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | DPI for delivery of moisture-sensitive drugs |
TWI274641B (en) * | 2005-08-30 | 2007-03-01 | Rexon Ind Corp Ltd | Cutting machine |
ES2394589T3 (en) | 2007-12-14 | 2013-02-04 | Aerodesigns, Inc | Supply of food products transformable in aerosol |
US9463161B2 (en) * | 2009-05-29 | 2016-10-11 | Pearl Therapeutics, Inc. | Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
JP6454323B2 (en) | 2013-03-15 | 2019-01-16 | パール セラピューティクス,インコーポレイテッド | Method and system for conditioning particulate crystalline materials |
MX2015013845A (en) | 2013-04-01 | 2016-05-09 | Pulmatrix Inc | Tiotropium dry powders. |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000074754A2 (en) * | 1999-06-05 | 2000-12-14 | Innovata Biomed Limited | Delivery system |
WO2001027210A1 (en) * | 1999-10-11 | 2001-04-19 | Ml Laboratories Plc | Medicament delivery device with moisture resistant coating |
US20030136405A1 (en) * | 2002-01-24 | 2003-07-24 | Joachim Goede | Pharmaceutical powder cartridge, and inhaler equipped with same |
WO2003084502A1 (en) * | 2002-04-09 | 2003-10-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalation kit comprisung inhalable powder of tiotropium |
WO2003086515A1 (en) * | 2002-04-12 | 2003-10-23 | Microdrug Ag | A device constituting a powder air-razor |
WO2003086517A1 (en) * | 2002-04-12 | 2003-10-23 | Microdrug Ag | De-aggregating and dispersing dry medicament powder into air |
WO2003086516A1 (en) * | 2002-04-12 | 2003-10-23 | Microdrug Ag | Therapeutic dry powder preparation |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH24267A (en) * | 1980-02-15 | 1990-05-29 | Glaxo Group Ltd | Androstane carbothioates and pharmaceutical compositions containing the same |
DE3274065D1 (en) * | 1981-07-08 | 1986-12-11 | Draco Ab | POWDER INHALATOR |
CA1224992A (en) * | 1982-10-08 | 1987-08-04 | Robert E. Newell | Device for administering medicament to patients |
ZW6584A1 (en) * | 1983-04-18 | 1985-04-17 | Glaxo Group Ltd | Phenethanolamine derivatives |
US5270305A (en) * | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
US6536427B2 (en) * | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
GB9004781D0 (en) * | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US5826633A (en) * | 1996-04-26 | 1998-10-27 | Inhale Therapeutic Systems | Powder filling systems, apparatus and methods |
US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
EP1862164A3 (en) * | 1998-11-13 | 2012-12-26 | Jagotec AG | Dry powder for inhalation |
SE517806C2 (en) * | 1999-11-11 | 2002-07-16 | Microdrug Ag | Dosing device for inhaler |
SE9904706D0 (en) * | 1999-12-21 | 1999-12-21 | Astra Ab | An inhalation device |
GB0009468D0 (en) * | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formulations for use in inhaler devices |
PE20011227A1 (en) * | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | PHARMACEUTICAL FORMULATIONS FOR DRY POWDER INHALERS IN THE FORM OF HARD AGGLOMERATES |
GB0015043D0 (en) * | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
SE517225C2 (en) * | 2000-09-21 | 2002-05-14 | Microdrug Ag | Optimization of an electrostatically dosed dry powder inhaler |
ES2227268T3 (en) * | 2000-10-12 | 2005-04-01 | BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG | NEW POWDER FOR INHALATION WITH CONTENT IN TIOTROPY. |
US20030078947A1 (en) * | 2001-10-12 | 2003-04-24 | Intel Corporation | Methods for assigning unique identifiers in a distributed fault tolerant application |
US6591832B1 (en) * | 2002-02-21 | 2003-07-15 | Saint-Gobain Calmar Inc. | Dry powder dispenser |
US20030235538A1 (en) * | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
GB0225621D0 (en) * | 2002-11-02 | 2002-12-11 | Glaxo Group Ltd | Medicament carrier |
SE0303571D0 (en) * | 2003-12-03 | 2003-12-22 | Microdrug Ag | Medical product for moisture-sensitive drugs |
SE0303569L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | DPI for delivery of moisture-sensitive drugs |
SE0303270L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Method of administration of tiotropium |
SE0303570L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Moisture-sensitive medical product |
SE0303269L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medical product |
SE0402345L (en) * | 2004-09-24 | 2006-03-25 | Mederio Ag | Measured drug dose |
-
2003
- 2003-12-03 SE SE0303270A patent/SE0303270L/en unknown
- 2003-12-08 US US10/729,024 patent/US20050121026A1/en not_active Abandoned
-
2004
- 2004-12-02 ES ES04801708T patent/ES2333725T3/en active Active
- 2004-12-02 CA CA002547660A patent/CA2547660A1/en not_active Abandoned
- 2004-12-02 AU AU2004294887A patent/AU2004294887B2/en active Active
- 2004-12-02 DE DE602004024261T patent/DE602004024261D1/en active Active
- 2004-12-02 DK DK04801708.1T patent/DK1991202T3/en active
- 2004-12-02 EP EP04801708A patent/EP1991202B1/en active Active
- 2004-12-02 SI SI200431340T patent/SI1991202T1/en unknown
- 2004-12-02 AT AT04801708T patent/ATE448776T1/en active
- 2004-12-02 PL PL04801708T patent/PL1991202T3/en unknown
- 2004-12-02 WO PCT/SE2004/001791 patent/WO2005053645A1/en active Application Filing
- 2004-12-02 PT PT04801708T patent/PT1991202E/en unknown
- 2004-12-02 ZA ZA200604254A patent/ZA200604254B/en unknown
-
2006
- 2006-06-08 US US11/448,725 patent/US20070110678A1/en not_active Abandoned
-
2010
- 2010-01-05 CY CY20101100009T patent/CY1110625T1/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000074754A2 (en) * | 1999-06-05 | 2000-12-14 | Innovata Biomed Limited | Delivery system |
WO2001027210A1 (en) * | 1999-10-11 | 2001-04-19 | Ml Laboratories Plc | Medicament delivery device with moisture resistant coating |
US20030136405A1 (en) * | 2002-01-24 | 2003-07-24 | Joachim Goede | Pharmaceutical powder cartridge, and inhaler equipped with same |
WO2003084502A1 (en) * | 2002-04-09 | 2003-10-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalation kit comprisung inhalable powder of tiotropium |
WO2003086515A1 (en) * | 2002-04-12 | 2003-10-23 | Microdrug Ag | A device constituting a powder air-razor |
WO2003086517A1 (en) * | 2002-04-12 | 2003-10-23 | Microdrug Ag | De-aggregating and dispersing dry medicament powder into air |
WO2003086516A1 (en) * | 2002-04-12 | 2003-10-23 | Microdrug Ag | Therapeutic dry powder preparation |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11116721B2 (en) | 2009-02-26 | 2021-09-14 | Glaxo Group Limited | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
US11090294B2 (en) | 2009-12-01 | 2021-08-17 | Glaxo Group Limited | Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist |
Also Published As
Publication number | Publication date |
---|---|
PL1991202T3 (en) | 2010-05-31 |
EP1991202A1 (en) | 2008-11-19 |
AU2004294887A1 (en) | 2005-06-16 |
DE602004024261D1 (en) | 2009-12-31 |
DK1991202T3 (en) | 2010-04-06 |
SE0303270L (en) | 2005-06-04 |
SE0303270D0 (en) | 2003-12-03 |
US20050121026A1 (en) | 2005-06-09 |
ATE448776T1 (en) | 2009-12-15 |
SI1991202T1 (en) | 2010-03-31 |
ZA200604254B (en) | 2008-05-28 |
PT1991202E (en) | 2009-12-10 |
ES2333725T3 (en) | 2010-02-26 |
CY1110625T1 (en) | 2015-04-29 |
AU2004294887B2 (en) | 2009-12-24 |
CA2547660A1 (en) | 2005-06-16 |
EP1991202B1 (en) | 2009-11-18 |
US20070110678A1 (en) | 2007-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070110678A1 (en) | Method for administration of tiotropium | |
US5642728A (en) | System for dispensing pharmaceutically active compounds | |
US6250300B1 (en) | System for dispensing pharmaceutically active compounds | |
US20040204440A1 (en) | Composition, device, and method for treating sexual dysfunction via inhalation | |
IL175887A (en) | A medical product comprising tiotropium loaded in a moisture-proof container | |
US20050042174A1 (en) | Combined doses | |
EP1675635B1 (en) | a multi-substance dry powder inhaler device | |
US20050053553A1 (en) | Combined doses of formoterol and fluticasone | |
US20050063911A1 (en) | Combined doses of formoterol and an anticholinergic agent | |
WO2004110404A1 (en) | Combined doses of tiotropium and fluticasone | |
EP2957552B1 (en) | Vilanterol formulations | |
US20040258624A1 (en) | Combined doses | |
US20050042175A1 (en) | Combined doses of formoterol and budesonide | |
WO2005053647A1 (en) | Medical product containing tiotropium | |
COL et al. | Salbutamol powder, administered via a multidose and a single-dose powder inhaler, in the prevention of exercise-induced asthma in children | |
DE202005004662U1 (en) | Dose of a pharmaceutical dry powder for inhaling, comprises a medicament chosen for formation of an anti-choline agent or a salt, a hydrate, a solvent and their mixtures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004294887 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006/04254 Country of ref document: ZA Ref document number: 200604254 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2547660 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2004294887 Country of ref document: AU Date of ref document: 20041202 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004294887 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004801708 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3717/DELNP/2006 Country of ref document: IN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 04801708 Country of ref document: EP Kind code of ref document: A1 |